Arvinas Stock Analysis

Arvinas Stock Analysis Notes

About 92.0% of the company shares are held by institutions such as insurance companies. The book value of Arvinas was presently reported as 8.16. The company has Price/Earnings To Growth (PEG) ratio of 0.28. Arvinas recorded a loss per share of 2.77. The entity had not issued any dividends in recent years. Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Arvinas, Inc. was founded in 2013 and is based in New Haven, Connecticut. Arvinas operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 280 people. For more info on Arvinas please contact John Houston at 203 535 1456 or go to https://www.arvinas.com.

Arvinas Investment Alerts

Arvinas Upcoming and Recent Events

Arvinas Largest EPS Surprises

View All Earnings Estimates

Arvinas Environmental, Social, and Governance (ESG) Scores

Arvinas Stock Institutional Investors

Note, although Arvinas' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Arvinas Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.22 B.

Arvinas Profitablity

The company has Profit Margin (PM) of (0.76) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.98) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.98.

Management Efficiency

Arvinas has return on total asset (ROA) of (0.1305) % which means that it has lost $0.1305 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3256) %, meaning that it created substantial loss on money invested by shareholders. Arvinas' management efficiency ratios could be used to measure how well Arvinas manages its routine affairs as well as how well it operates its assets and liabilities. As of the 26th of February 2025, Return On Tangible Assets is likely to drop to -0.19. In addition to that, Return On Capital Employed is likely to drop to -0.3. At this time, Arvinas' Fixed Asset Turnover is very stable compared to the past year. As of the 26th of February 2025, Asset Turnover is likely to grow to 0.25, while Total Assets are likely to drop about 802.9 M.

Technical Drivers

As of the 26th of February, Arvinas shows the Standard Deviation of 4.17, risk adjusted performance of (0.05), and Mean Deviation of 3.27. Arvinas technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Arvinas Price Movement Analysis

Arvinas Insider Trading Activities

Arvinas Outstanding Bonds

Arvinas Predictive Daily Indicators

Arvinas Corporate Filings

Arvinas Forecast Models

Arvinas' time-series forecasting models are one of many Arvinas' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Arvinas' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Arvinas prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Arvinas shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Arvinas. By using and applying Arvinas Stock analysis, traders can create a robust methodology for identifying Arvinas entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Arvinas analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Arvinas analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Arvinas stock analysis indicators help investors evaluate how Arvinas stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Arvinas shares will generate the highest return on investment. By understating and applying Arvinas stock analysis, traders can identify Arvinas position entry and exit signals to maximize returns.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arvinas. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. To learn how to invest in Arvinas Stock, please use our How to Invest in Arvinas guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arvinas. If investors know Arvinas will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arvinas listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Arvinas is measured differently than its book value, which is the value of Arvinas that is recorded on the company's balance sheet. Investors also form their own opinion of Arvinas' value that differs from its market value or its book value, called intrinsic value, which is Arvinas' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arvinas' market value can be influenced by many factors that don't directly affect Arvinas' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Arvinas' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arvinas is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arvinas' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.